Indivior PLC (LON:INDV - Get Free Report)'s share price was up 9.9% during mid-day trading on Tuesday . The company traded as high as GBX 1,090 ($14.88) and last traded at GBX 1,084 ($14.79). Approximately 496,685 shares traded hands during mid-day trading, a decline of 39% from the average daily volume of 808,406 shares. The stock had previously closed at GBX 986 ($13.46).
Indivior Stock Performance
The firm's 50 day moving average is GBX 944.53 and its 200 day moving average is GBX 864.18. The company has a debt-to-equity ratio of -170.06, a quick ratio of 1.52 and a current ratio of 0.83. The stock has a market cap of £1.77 billion, a P/E ratio of -936.93, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19.
Insider Transactions at Indivior
In other Indivior news, insider Juliet Thompson acquired 3,850 shares of the firm's stock in a transaction dated Wednesday, June 11th. The stock was purchased at an average price of GBX 1,388 ($18.94) per share, for a total transaction of £53,438 ($72,932.99). Corporate insiders own 3.44% of the company's stock.
About Indivior
(
Get Free Report)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
See Also
Before you consider Indivior, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.
While Indivior currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
